Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate

Fig. 2

Maciej Banach is Professor of Cardiology at the Medical University of Lodz and President of the Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland. He is also Visiting Professor at the University of Alabama at Birmingham, Birmingham, AL, USA, and Victor Babes University of Medicine and Pharmacy, Timisoara, Romania. He is a member of the Executive Committee of the European Atherosclerosis Society (EAS), Founder and Head of the Polish Lipid Association (PoLA), and the founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. His main area of research concerns hypertension, lipid disorders, dyslipidemia therapy and new drugs in CVD therapy

Back to article page